Actinium Pharmaceuticals Announces Plans For Iomab™-B Phase 3 Pivotal Trial Following Meeting With FDA
Plus, new BlackRock funds, manager changes, and more.
Plus, private equity giants go wild, Medtronic posts a strong quarter, and more.
Plus, news on new Turner funds, Causeway's emerging-markets fund, and more.
Technology and communications keep getting pounded in 2002.
Health-care Sector Although the median health-care stock is slightly overvalued in our opinion, we're very excited by the prospects of the health-care sector. Demographics--especially older, wealthier populations--give many of the firms we cover a strong outlook in 2007 and beyond. We're excited ...
M&A activity contributes to surge.